FdaApplication
ANDA 210352
Identifiers
- fda_app_no: ANDA210352
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2024-12-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BEXAROTENE | BEXAROTENE | 75MG | CAPSULE;ORAL |
1 product